SK Bioscience Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 28.99%

SK Bioscience Co Ltd (302440) has an Asset Resilience Ratio of 28.99% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 302440 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩847.30 Billion

≈ $574.20 Million USD Cash + Short-term Investments

Total Assets

₩2.92 Trillion

≈ $1.98 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2024)

This chart shows how SK Bioscience Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 302440 total assets.

Liquid Assets Composition Over Time

This chart breaks down SK Bioscience Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read SK Bioscience Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩847.30 Billion	28.99%
Total Liquid Assets	₩847.30 Billion	28.99%

Asset Resilience Insights

Very High Liquidity: SK Bioscience Co Ltd maintains exceptional liquid asset reserves at 28.99% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

SK Bioscience Co Ltd Industry Peers by Asset Resilience Ratio

Compare SK Bioscience Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for SK Bioscience Co Ltd (2018–2024)

The table below shows the annual Asset Resilience Ratio data for SK Bioscience Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	29.73%	₩845.41 Billion ≈ $572.92 Million	₩2.84 Trillion ≈ $1.93 Billion	-32.19pp
2023-12-31	61.92%	₩1.15 Trillion ≈ $777.38 Million	₩1.85 Trillion ≈ $1.26 Billion	+3.31pp
2022-12-31	58.62%	₩1.26 Trillion ≈ $850.85 Million	₩2.14 Trillion ≈ $1.45 Billion	-14.73pp
2021-12-31	73.34%	₩1.55 Trillion ≈ $1.05 Billion	₩2.11 Trillion ≈ $1.43 Billion	+40.66pp
2020-12-31	32.68%	₩183.74 Billion ≈ $124.52 Million	₩562.23 Billion ≈ $381.02 Million	+12.85pp
2019-12-31	19.82%	₩80.09 Billion ≈ $54.27 Million	₩403.98 Billion ≈ $273.77 Million	-4.81pp
2018-12-31	24.63%	₩99.19 Billion ≈ $67.22 Million	₩402.71 Billion ≈ $272.91 Million	--

pp = percentage points

About SK Bioscience Co Ltd

KO:302440 Korea Biotechnology

Market Cap

$1.95 Billion

₩2.88 Trillion KRW

Market Cap Rank

#6250 Global

#149 in Korea

Share Price

₩36750.00

Change (1 day)

-2.78%

52-Week Range

₩32500.00 - ₩60100.00

All Time High

₩335500.00